Chenault et al., 1990 - Google Patents
Synchronization of estrus with melengestrol acetate and prostaglandin F2α in beef and dairy heifersChenault et al., 1990
- Document ID
- 2149481906635662596
- Author
- Chenault J
- McAllister J
- Kasson C
- Publication year
- Publication venue
- Journal of animal science
External Links
Snippet
Abstract Beef (n= 783) and dairy (n= 209) heifers at 14 locations were used to evaluate the efficacy of feeding melengestrol acetate (MGA;. 5 mg/d) for 7 d followed by an im injection of 25 mg prostaglandin F2α (PGF) on the last day of MGA feeding (MGA+ PGF) to synchronize …
- 230000012173 estrus 0 title abstract description 80
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
- A61D19/00—Instruments or methods for reproduction or fertilisation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Squires et al. | Effect of an oral progestin on the estrous cycle and fertility of mares | |
Sanchez et al. | Pregnancy rate is greater when the corpus luteum is present during the period of progestin treatment to synchronize time of estrus in cows and heifers | |
Wehrman et al. | Increasing exogenous progesterone during synchronization of estrus decreases endogenous 17β-estradiol and increases conception in cows | |
Pursley et al. | Pregnancy rates per artificial insemination for cows and heifers inseminated at a synchronized ovulation or synchronized estrus | |
Patterson et al. | Control of the bovine estrous cycle with melengestrol acetate (MGA): A review | |
US5130137A (en) | Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use in treating benign ovarian secretory disorders | |
Thompson et al. | Follicular, hormonal, and pregnancy responses of early postpartum suckled beef cows to GnRH, norgestomet, and prostaglandin F2 α | |
Nellor et al. | The hormonal control of estrus and ovulation in the beef heifer | |
Holtan et al. | Estrus, ovulation and conception following synchronization with progesterone, prostaglandin F2α and human chorionic gonadotropin in pony mares | |
Chenault et al. | Synchronization of estrus with melengestrol acetate and prostaglandin F2α in beef and dairy heifers | |
Kraeling et al. | Synchronization of estrus in swine with allyl trenbolone (RU-2267) | |
Stevenson et al. | Estrous synchronization and fertility in gilts after 14-or 18-day feeding of altrenogest beginning at estrus or diestrus | |
Moore | The control of time of oestrus and ovulation and the induction of superovulation in cattle | |
Hansel et al. | The applications of ovulation control | |
Kwun et al. | Hormonal requirements for implantation and pregnancy in the ovariectomized rabbit | |
Schiewe et al. | Human menopausal gonadotropin induces ovulation in sheep, but embryo recovery after prostaglandin F2α synchronization is compromised by premature luteal regression | |
Estill | Current concepts in estrus synchronization in swine | |
Rowe et al. | Comparison of two sources of gonadotropin for estrus synchronization in does | |
Roche et al. | The fertility of heifers inseminated at predetermined intervals following treatment with MGA and HCG to control ovulation | |
Lokhande et al. | Fertility on synchronized estrus in crossbred (Bos taurus× Bos indicus) heifers | |
Xu et al. | Synchronization of estrus with PGF2α administered 18 days after a progesterone treatment in lactating dairy cows | |
Mattos et al. | Effect of an implant containing the GnRH agonist deslorelin on secretion of LH, ovarian activity and milk yield of postpartum dairy cows | |
JP2515106B2 (en) | Drugs to stagger endometrial maturation | |
Corson et al. | Leuprolide acetate-prepared in vitro fertilization-gamete intrafallopian transfer cycles: efficacy versus controls and cost analysis | |
Squires | Use of progestins in open and pregnant mares |